产品编号 :
Cas No. :
CAS No. |
158681-13-1 |
|---|---|
英文名称 |
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride |
别名 |
RIMONABANT HYDROCHLORIDE;5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-1-piperidinyl-1h-pyrazole-3-carboxamide monohydrochloride;ACOMPLIA;ACOMPLIA (RIMONABANT;RIMONABANT HCL;Rimonabant(Acomplia);RimonabantConsultedStandard;Acomplia, SR141716 |
标准英文名 |
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride |
分子式 |
C22H22Cl4N4O |
分子量 |
500.26 |
精确分子量 |
498.05 |
SMILES |
CC1=C(C2=CC=C(Cl)C=C2)N(C2=CC=C(Cl)C=C2Cl)N=C1C(=O)NN1CCCCC1.Cl |
标准SMILES |
Cl.CC1=C(C2C=CC(Cl)=CC=2)N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl |
用途 |
Rimonabant hydrochloride is a cannabinoid receptor-1 (CB1) antagonist used for the treatment of obesity, nicotine addiction, hypertension, dyslipidemia, type 2 diabetes, and metabolic syndrome; it also reduces cholesterol levels and helps prevent heart disease and diabetes in obese individuals. |
InChIKey |
REOYOKXLUFHOBV-UHFFFAOYSA-N |
|
|
评论 |
|---|